Form 4: Amphenol Executive Sells 160,000 Shares Following Option Exercise Under Pre-Arranged Plan
Insider Transaction Report
William J. Doherty, President of Amphenol's CS Division, sold 160,000 shares of Class A Common Stock for approximately $89.54 per share after exercising stock options, as part of a pre-arranged Rule 10b5-1 trading plan.
Summary
- William J. Doherty, President of the CS Division and a Director at Amphenol Corp /DE/ (APH), reported transactions involving the company's Class A Common Stock.
- On May 30, 2025, Mr. Doherty acquired 160,000 shares of Class A Common Stock by exercising stock options at a price of $22.5525 per share.
- Concurrently, on May 30, 2025, Mr. Doherty disposed of 160,000 shares of Class A Common Stock at a weighted average sale price of $89.5407 per share.
- The sale price ranged from $89.5150 to $89.6450 across multiple trades.
- Following these transactions, Mr. Doherty directly owns 0 shares of Class A Common Stock.
- He continues to directly own 226,000 derivative securities in the form of stock options.
- The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale could be seen negatively, the explicit mention of a Rule 10b5-1 plan indicates a pre-scheduled transaction for personal financial planning, mitigating negative implications.
Positives
- The executive's ability to exercise options and sell shares indicates a significant personal gain from long-term compensation, reflecting the company's stock appreciation.
- The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled sale not based on immediate, non-public information, which can mitigate negative perceptions of insider selling.
Negatives
- The sale of 160,000 shares by a key executive, even if pre-planned, reduces their direct equity stake in the company, which some investors might view with caution.
Risks
- While executed under a 10b5-1 plan, large insider sales can sometimes lead to negative market sentiment or speculation, potentially impacting short-term stock performance.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing reports an individual executive's stock transaction and does not provide broader industry context or trends. It is a routine disclosure of insider trading activity.
Comparison to Industry Standards
- As a Form 4 filing, this document reports an individual insider transaction and does not contain information suitable for comparison to global industry benchmarks, comparable companies, or project results.
Stakeholder Impact
- Shareholders may note the reduction in direct equity ownership by a key executive, though the pre-planned nature of the sale under Rule 10b5-1 typically lessens concerns.
Next Steps
- No specific future actions, events, or milestones for the company are mentioned in this insider transaction report.
Key Dates
| Date | Description |
|---|---|
| 05/21/2021 | Date stock options became exercisable. |
| 05/30/2025 | Date of stock option exercise and subsequent sale of Class A Common Stock. |
| 06/02/2025 | Date the Form 4 filing was signed. |
| 05/21/2030 | Expiration date of the stock options. |
Keywords
Amphenol, APH, SEC Form 4, Insider Trading, Stock Options, Executive Compensation, Rule 10b5-1, Share Sale, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.